Septic shock: Lilly withdraws Xigris after 10 years on market
25 October 2011
Eleanor Malone
Please Login to read the full article.
25 October 2011
Eleanor Malone
Please Login to read the full article.
RELATED CONTENT
NEWS
- Lilly consigns shocking Xigris to critical care in investor- and state-backed biotech
- Affymax pops on FDA affirmation of peginesatide efficacy in CKD anaemia
- Stockwatch: Investing in pharma will pay dividends
- Data 'missingness' leads to US FDA panel loss for Janssen's Xarelto in ACS
ANALYSIS
Other Informa Analysis
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
